1. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial. Issue 11 (November 2021) Authors: Tsoukas, Michael A; Majdpour, Dorsa; Yale, Jean-François; Fathi, Anas El; Garfield, Natasha; Rutkowski, Joanna; Rene, Jennifer; Legault, Laurent; Haidar, Ahmad Journal: Lancet Issue: Volume 3:Issue 11(2021) Page Start: e723 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A pilot non‐inferiority randomized controlled trial to assess automatic adjustments of insulin doses in adolescents with type 1 diabetes on multiple daily injections therapy. Issue 6 (11th June 2020) Authors: El Fathi, Anas; Palisaitis, Emilie; von Oettingen, Julia E.; Krishnamoorthy, Preetha; Kearney, Robert E.; Legault, Laurent; Haidar, Ahmad Journal: Pediatric diabetes Issue: Volume 21:Issue 6(2020) Page Start: 950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Alleviating carbohydrate counting with a FiASP‐plus‐pramlintide closed‐loop delivery system (artificial pancreas): Feasibility and pilot studies. Issue 9 (21st June 2021) Authors: Tsoukas, Michael A.; Cohen, Elisa; Legault, Laurent; von Oettingen, Julia E.; Yale, Jean‐François; Vallis, Michael; Odabassian, Madison; El Fathi, Anas; Rutkowski, Joanna; Jafar, Adnan; Ghanbari, Milad; Gouchie‐Provencher, Nikita; René, Jennifer; Palisaitis, Emilie; Haidar, Ahmad Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 9(2021) Page Start: 2090 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Issue 1 (January 2015) Authors: Haidar, Ahmad; Legault, Laurent; Messier, Virginie; Mitre, Tina Maria; Leroux, Catherine; Rabasa-Lhoret, Rémi Journal: Lancet Issue: Volume 3:Issue 1(2015) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Issue 1 (January 2015) Authors: Haidar, Ahmad; Legault, Laurent; Messier, Virginie; Mitre, Tina Maria; Leroux, Catherine; Rabasa-Lhoret, Rémi Journal: Lancet Issue: Volume 3:Issue 1(2015) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use. Issue 1 (9th November 2016) Authors: Taleb, Nadine; Haidar, Ahmad; Messier, Virginie; Gingras, Véronique; Legault, Laurent; Rabasa‐Lhoret, Rémi Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 1(2017) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Glucagon‐like peptide‐1 receptor agonists as adjunctive treatment for type 1 diabetes: Renewed opportunities through tailored approaches?. Issue 5 (2nd March 2022) Authors: Kobayati, Alessandra; Haidar, Ahmad; Tsoukas, Michael A. Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 5(2022) Page Start: 769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-term use of the hybrid artificial pancreas by adjusting carbohydrate ratios and programmed basal rate: A reinforcement learning approach. (March 2021) Authors: Jafar, Adnan; Fathi, Anas El; Haidar, Ahmad Journal: Computer methods and programs in biomedicine Issue: Volume 200(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Outpatient 60‐hour day‐and‐night glucose control with dual‐hormone artificial pancreas, single‐hormone artificial pancreas, or sensor‐augmented pump therapy in adults with type 1 diabetes: An open‐label, randomised, crossover, controlled trial. Issue 5 (8th March 2017) Authors: Haidar, Ahmad; Messier, Virginie; Legault, Laurent; Ladouceur, Martin; Rabasa‐Lhoret, Rémi Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 5(2017) Page Start: 713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial. Issue 8 (August 2015) Authors: Haidar, Ahmad; Legault, Laurent; Matteau-Pelletier, Laurence; Messier, Virginie; Dallaire, Maryse; Ladouceur, Martin; Rabasa-Lhoret, Rémi Journal: Lancet Issue: Volume 3:Issue 8(2015) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗